PMC:7271924 / 24149-24466 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T476","span":{"begin":39,"end":46},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T477","span":{"begin":85,"end":92},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T478","span":{"begin":158,"end":166},"obj":"SP_7"},{"id":"T479","span":{"begin":204,"end":212},"obj":"CL:0000233;GO:0030168"},{"id":"T480","span":{"begin":213,"end":222},"obj":"GO:0030168"},{"id":"T481","span":{"begin":272,"end":284},"obj":"GO:0065007"},{"id":"T482","span":{"begin":285,"end":294},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T483","span":{"begin":295,"end":303},"obj":"CHEBI:9574;CHEBI:9574"},{"id":"T484","span":{"begin":305,"end":311},"obj":"CHEBI:5054;CHEBI:5054"},{"id":"T46556","span":{"begin":39,"end":46},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T17255","span":{"begin":85,"end":92},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T12103","span":{"begin":158,"end":166},"obj":"SP_7"},{"id":"T58612","span":{"begin":204,"end":212},"obj":"CL:0000233;GO:0030168"},{"id":"T3543","span":{"begin":213,"end":222},"obj":"GO:0030168"},{"id":"T1406","span":{"begin":272,"end":284},"obj":"GO:0065007"},{"id":"T29182","span":{"begin":285,"end":294},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T31361","span":{"begin":295,"end":303},"obj":"CHEBI:9574;CHEBI:9574"},{"id":"T89081","span":{"begin":305,"end":311},"obj":"CHEBI:5054;CHEBI:5054"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":39,"end":46},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T2","span":{"begin":39,"end":46},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"},{"id":"T3","span":{"begin":85,"end":92},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T4","span":{"begin":85,"end":92},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"612","span":{"begin":167,"end":175},"obj":"Species"},{"id":"613","span":{"begin":39,"end":46},"obj":"Chemical"},{"id":"614","span":{"begin":64,"end":92},"obj":"Chemical"},{"id":"635","span":{"begin":158,"end":166},"obj":"Disease"},{"id":"642","span":{"begin":295,"end":303},"obj":"Gene"}],"attributes":[{"id":"A612","pred":"tao:has_database_id","subj":"612","obj":"Tax:9606"},{"id":"A613","pred":"tao:has_database_id","subj":"613","obj":"MESH:D006493"},{"id":"A614","pred":"tao:has_database_id","subj":"614","obj":"MESH:D006495"},{"id":"A635","pred":"tao:has_database_id","subj":"635","obj":"MESH:C000657245"},{"id":"A642","pred":"tao:has_database_id","subj":"642","obj":"Gene:2147"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T291","span":{"begin":39,"end":46},"obj":"Body_part"},{"id":"T292","span":{"begin":85,"end":92},"obj":"Body_part"},{"id":"T293","span":{"begin":204,"end":212},"obj":"Body_part"}],"attributes":[{"id":"A291","pred":"fma_id","subj":"T291","obj":"http://purl.org/sig/ont/fma/fma82839"},{"id":"A292","pred":"fma_id","subj":"T292","obj":"http://purl.org/sig/ont/fma/fma82839"},{"id":"A293","pred":"fma_id","subj":"T293","obj":"http://purl.org/sig/ont/fma/fma62851"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T80","span":{"begin":158,"end":166},"obj":"Disease"}],"attributes":[{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T330","span":{"begin":213,"end":222},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T331","span":{"begin":236,"end":246},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T309","span":{"begin":39,"end":46},"obj":"Chemical"},{"id":"T310","span":{"begin":85,"end":92},"obj":"Chemical"},{"id":"T311","span":{"begin":285,"end":294},"obj":"Chemical"}],"attributes":[{"id":"A309","pred":"chebi_id","subj":"T309","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A310","pred":"chebi_id","subj":"T310","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A311","pred":"chebi_id","subj":"T311","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T54","span":{"begin":213,"end":222},"obj":"http://purl.obolibrary.org/obo/GO_0023052"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}

{"project":"MyTest","denotations":[{"id":"32574271-32220112-34514738","span":{"begin":177,"end":180},"obj":"32220112"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}

{"project":"TEST0","denotations":[{"id":"32574271-202-209-2882330","span":{"begin":177,"end":180},"obj":"[\"32220112\"]"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}

{"project":"2_test","denotations":[{"id":"32574271-32220112-34514738","span":{"begin":177,"end":180},"obj":"32220112"}],"text":"ant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179).\nFigure 5 Simplified platelet signaling and receptor activation during disease with main dysregulated molecules thrombin, fibrin(ogen)"}